[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bio-Path Holdings Inc (BPTH)

Bio-Path Holdings Inc (BPTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Bio-Path: Q1 Earnings Snapshot

Bio-Path: Q1 Earnings Snapshot

BPTH : 0.0406 (+16.00%)
Bio-Path: Q3 Earnings Snapshot

Bio-Path: Q3 Earnings Snapshot

BPTH : 0.0406 (+16.00%)
Bio-Path: Q2 Earnings Snapshot

Bio-Path: Q2 Earnings Snapshot

BPTH : 0.0406 (+16.00%)
Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum

BPTH : 0.0406 (+16.00%)
Bio-Path Holdings Provides Clinical and Operational Update

BPTH : 0.0406 (+16.00%)
Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025

BPTH : 0.0406 (+16.00%)
Bio-Path: Q1 Earnings Snapshot

Bio-Path: Q1 Earnings Snapshot

BPTH : 0.0406 (+16.00%)
Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients

BPTH : 0.0406 (+16.00%)
Bio-Path Holdings Reports Full Year 2024 Financial Results

BPTH : 0.0406 (+16.00%)
Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients

BPTH : 0.0406 (+16.00%)

Barchart Exclusives

Bill Ackman Just Bought Visa Stock. What Barchart Options Data Says Could Come Next for V Investors.
Bill Ackman reveals a fresh stake in Visa stock. Options pricing also suggests V shares will rip higher in the weeks ahead. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.